Thomas B. Cueni

Former Director General @IFPMA. Former journalist and diplomat representing biopharma in shared pursuit of #globalhealth & #SDGs. #TeamVaccines

[Thomas B. Cueni @ThomasCueni]

The right policies & incentives establish a shared foundation on which to prevent & respond to future pandemics, together.

Innovation delivered during #COVID19, but not equitably enough. My thoughts on how we build on #C19LessonsLearned to do better next time.

[IFPMA @IFPMA]

To understand better how the pharmaceutical industry is #AlwaysInnovating to deliver healthcare solutions and ensure global health security, check out @ThomasCueni’s op-ed on @devex:

📰https://t.co/Kj84mIxsmG

[Albert Bourla @AlbertBourla]

I am humbled and honored to assume the role of President of the @IFPMA. This important organization consists of more than 90 pharmaceutical companies and associations and works closely with the @UN system to advance global health through discovering, developing and delivering medicines and vaccines. This talented group of colleagues are as passionate as I am about improving the lives of people everywhere. https://t.co/vR8byOtrZr

[Ngozi Okonjo-Iweala @NOIweala]

Instructive and Constructive first Business Advisory Group meeting today. Great to listen to advice and feedback on Digital Trade, Sustainability, WTO reform, Business Responses in the Face of geopolitical tensions, MSMEs and Inclusive Trade and Recentering the WTO on people! With members @PaulPolman @ICCSecGen @Aig_Imoukhuede @ThomasCueni @tarek_sultan and others

[Thomas B. Cueni @ThomasCueni]

Global health progress relies on a robust innovation ecosystem. Thanks to pharmaceutical innovation, #tuberculosis treatments are being adapted, enabling shorter, simplified regimens. #endTB https://t.co/iU6OXpJFKk

[IFPMA @IFPMA]

Every year, more than 10 million people fall ill with tuberculosis, resulting in 1.6 million deaths. That’s why we’re constantly working on new treatments to slow the spread of #TB. #AlwaysInnovating https://t.co/edIdQNBYqw

[Thomas B. Cueni @ThomasCueni]

As we look at how we can be better prepared in the future, it’s important not to compromise what worked well – our ability to innovate and fast access to pathogens – whilst we address the areas well fell short such as ensuring equitable roll-out. Thanks to @ForeignPolicy ⬇️

[Foreign Policy @ForeignPolicy]

Happening now at #FPGlobalHealthForum: @IFPMA’s @ThomasCueni takes the stage to speak with FP Analytics’ Dr. Mayesha Alam on the role of industry in navigating future pandemics. https://t.co/8l0Jo1HMf4

[Thomas B. Cueni @ThomasCueni]

Pharmaceutical #innovation has driven incredible progress in how we diagnose, prevent & treat diseases. To unlock solutions to global health challenges we must protect what makes innovation possible. @IFPMA’s #AlwaysInnovating campaign tells this story⬇️
https://t.co/5VjQIwYPeQ

[Thomas B. Cueni @ThomasCueni]

This #WHA76, we joined other global health stakeholders from around the world to move forward meaningful dialogue on pandemic preparedness and #HealthforAll.

Read our industry's contributions to the discussions on #UHC, #NCDs, and health security.

➡️https://t.co/H14H1EKsvK

[IFPMA @IFPMA]

#WHA76 was a moment for the global health community to contribute their views on the best measures to prepare for future pandemics and achieve UHC. Our full statements on:

✅the Health Emergency Preparedness and Response Program (HEPR)
✅#UHC & #NCDs

➡️ https://t.co/af8aWCXcSb

[Thomas B. Cueni @ThomasCueni]

#WHA76 set an ambitious agenda, with conversations focused on reaching global goals and securing future health. Three highlights for me:

🌍Pandemic preparedness
⚕️The importance of #UHC
💥An engaged #youth

➡️My reflections here: https://t.co/pys7WgEQcw

[Foreign Policy Media Room @ForeignPolicyPR]

Thomas Cueni @ThomasCueni of @IFPMA: “Now I think we are concerned about climate change but are we concerned about the AMR as we should be.” The conversation on #Innovation4Health with @IFPMA continues below:

[Thomas B. Cueni @ThomasCueni]

I am looking forward to presenting the keynote address at this year’s AMIIF Innovation Week #SI23.

As we reflect on the past three years, coming together to discuss the value of #innovation & the importance of ethics & social value within industry is of great importance.

[AMIIF México @AMIIFMx]

Les presentamos uno de los paneles que forman parte de la Semana de la Innovación 2023, #SI23. ⁣
⁣
"Ética y valor social en la industria farmacéutica y el sector salud".⁣

📆 ⏰ 28 de marzo, presencial en Papalote Museo del Niño.⁣

Registro | https://t.co/G7Q77kUeYz

[STAT @statnews]

Opinion: The fungal crisis is here and desperately needs addressing https://t.co/fDDx8H7beu

[Thomas B. Cueni @ThomasCueni]

Je remercie @OIFrancophonie pour ce dialogue important, qui souligne les besoins et les attentes des pays pour une meilleure préparation aux pandémies, le renforcement des systèmes de santé et un meilleur accès aux produits de santé, en partenariat avec le secteur privé.

[Stéphanie Seydoux @S_Seydoux]

Avec les ambassadeurs de @OIFrancophonie nous évoquons les #PartenariatPublicPrivé , indispensables pour améliorer l’accès aux produits de santé lors de prochaines pandémies, et pour consolider les systèmes de santé. @IFPMA s’engage pour cela avec @WHO

[IFPMA @IFPMA]

Today, our DG @ThomasCueni writes about how the “politicization” of pathogen sharing undermines global health security and our collective ability to stop pandemics in their track. #ShareDataOnPathogens

Sponsored piece in @POLITICOEurope: https://t.co/gUajoELjcf

[Thomas B. Cueni @ThomasCueni]

I applaud Japan for its commitment to #UHC, one of our greatest opportunities to improve global health & well-being in the coming years.

[The Lancet @TheLancet]

"I am confident that the G7 members and other colleagues around the world will embrace human security and #UHC as a core principle of advancing global health..."

Ahead of hosting #G7Hiroshima in May, a Comment from Japan's Prime Minister: https://t.co/xSfzelDkbe

[Thomas B. Cueni @ThomasCueni]

As the threat of antimicrobial resistance continues to grow, we remain committed to supporting the @AMRActionFund. Today’s investment is welcomed news and an important step forward in the fight against #AMR.

https://t.co/qXzrqO78Mn

[AMR Action Fund @AMRActionFund]

We are thrilled to announce our investment into @BioVersys! The antibiotics they are developing target some of the highest-priority drug-resistant pathogens and could deliver significant benefits to patients suffering from life-threatening infections. https://t.co/GunkoIp57g #AMR

[Thomas B. Cueni @ThomasCueni]

This week, I had the pleasure of joining colleagues in Japan at an @NCDAccess event to discuss the link between #NCDs & UHC.

I applaud Japan for its commitment to #UHC & appreciate the efforts of #AccessAccelerated partners for their work.

[IFPMA @IFPMA]

Yesterday, our DG @ThomasCueni joined🌎leaders and experts at the @NCDAccess event in Japan to discuss how to achieve the global goal of #HealthforAll. Collectively shaping a strong NCD response is key.

Watch the full discussion ➡️https://t.co/WIEkQ24qn9

[Thomas B. Cueni @ThomasCueni]

My thoughts in the Journal of Infectious Diseases and Therapy on solutions toward equitable access to vaccines, diagnostics, and therapeutics during pandemics ⬇️#C19LessonsLearned

[IFPMA @IFPMA]

#C19LessonsLearned showed us that collective efforts are needed to achieve health equity & ensure health systems & delivery infrastructure are strengthened.

@IFPMA DG @ThomasCueni outlines solutions toward a healthier, safer & more equitable world➡️ https://t.co/xP4EIaUpIm

[Thomas B. Cueni @ThomasCueni]

To mark #UHCDay, I am pleased to join a timely conversation with leaders & colleagues on how integrating #NCDs into #UHC policy & packages is critical to ensuring sustained gains toward a healthy future for all.

📅 Dec 13
📍Tokyo or online
➡️https://t.co/INjcVoOsmA

[Access Accelerated @NCDAccess]

What lessons can be learned from addressing #NCDs as part of achieving #UHC? Hear from:

Dr Sunao Manabe,@DaiichiSankyoJP
Dr Eiji Hinoshita, @MHLWitter_en
Dr Hajime Inoue, @WorldBank
Ms Saba Husain, @LillyPad
Mr Thomas Cueni, @IFPMA

Sign up 👉🏽 https://t.co/vvuH5wwc4What lessons can be learned from addressing #NCDs as part of achieving #UHC? Hear from:

Dr Sunao Manabe,@DaiichiSankyoJP
Dr Eiji Hinoshita, @MHLWitter_en
Dr Hajime Inoue, @WorldBank
Ms Saba Husain, @LillyPad
Mr Thomas Cueni, @IFPMA

Sign up 👉🏽 https://t.co/vvuH5wwc4What lessons can be learned from addressing #NCDs as part of achieving #UHC? Hear from:

Dr Sunao Manabe,@DaiichiSankyoJP
Dr Eiji Hinoshita, @MHLWitter_en
Dr Hajime Inoue, @WorldBank
Ms Saba Husain, @LillyPad
Mr Thomas Cueni, @IFPMA

Sign up 👉🏽 https://t.co/vvuH5wwc4What lessons can be learned from addressing #NCDs as part of achieving #UHC? Hear from:

Dr Sunao Manabe,@DaiichiSankyoJP
Dr Eiji Hinoshita, @MHLWitter_en
Dr Hajime Inoue, @WorldBank
Ms Saba Husain, @LillyPad
Mr Thomas Cueni, @IFPMA

Sign up 👉🏽 https://t.co/vvuH5wwc4w

[Thomas B. Cueni @ThomasCueni]

Tomorrow, I look forward to speaking at the @Nikkei_cds @FT Communicable Diseases Conference where I will share my views on the #C19LessonsLearned and on the key role Japan plays in supporting #innovation, achieving #UHC and pandemic preparedness.

https://t.co/qvRYrTgUlJ